B. BRAUN SE

Company Overview

B. Braun SE, founded in 1839 in Germany, is a global provider of healthcare products and services. The company develops a broad portfolio of medical solutions, including products for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, cardiology, surgical core procedures, nutritional therapy, etc.

The company operates through four divisions: B. Braun Hospital Care, B. Braun Aesculap, B. Braun Outpatient Market, and B. Braun Avitum. B. Braun Aesculap focuses on therapeutic areas, including abdominal surgery, cardiothoracic surgery, interventional vascular therapy, neurosurgery orthopedic surgery, spine surgery, and sterile goods management. It offers surgical and interventional products under this segment.

B. Braun has over 64,000 employees across over 300 subsidiaries in 64 countries. Its portfolio includes 5,000 healthcare products.

Financial Highlights (FY 2024)

Company's Business Segments

• Hospital Care : Hospital Care uses integrated solutions to improve medical care at the hospital and beyond. Our products help give medical professionals more time to care for patients. Our ready-to-use pharmaceutical products and prepared parenteral nutrition in multi-chamber bags help us make clinical processes safer and more efficient. We offer products for the automated production of customized patient medication and nutrition for seriously ill patients, together with software solutions.
• Aesculap : Our wide range of practical processes for basic surgical and interventional processes help medical professionals provide the best possible care for the patient. In addition, we empower OR professionals to treat patients according to their individual needs using data-centric digital applications. We also offer digitalization solutions for sterile goods management that are adapted to specialists and processes to achieve clinical excellence while lowering costs. With all these integrated solutions, we are driving advancement in the field of surgery and intervention.
• Avitum : Avitum develops therapy systems for the needs of chronically ill patients. We use integrated solutions to make treatments simple and efficient while also improving quality of life and making work easier for medical professionals. For patients with other chronic conditions—such as chronic wounds, ostomies or urinary incontinence—we are refining our portfolio with products that are reliable and easy to use, even at home. Our focus on infection prevention and control is based on concepts that utilize advice and training to help reduce the risk of infection in all areas of medical treatment, wherever patient care takes place.